Background illustration for clinical trials search

Paid Clinical Trials Allentown

Discover 2,147 paid clinical trials in Allentown, Pennsylvania. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Cabozantinib With Ifosfamide in Relapsed/Refractory Sarcomas

for
Ewing Sarcoma, Osteosarcoma, Sarcomas
Location: Philadelphia PA, Aurora CO, San Francisco CA
Sponsor: Children's Hospital of Philadelphia

Sex: All

Age: 5 - 40

Code: NCT06156410

Phase1, Recruiting

The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use in Conjunction With VISITAG SURPOINT Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation.

for
Paroxysmal Atrial Fibrillation
Location: Philadelphia PA, Winchester VA, Richmond VA,
Sponsor: Heart Rhythm Clinical and Research Solutions, LLC

Sex: All

Age: 18+

Code: NCT06324201

Recruiting

CW2IP2: Imaging and Diagnostic Assessments

for
Tauopathies
Location: Philadelphia PA
Sponsor: University of Pennsylvania

Sex: All

Age: 40 - 70+

Code: NCT06083467

Recruiting

A Study of T3011 in Patients With BCG-Unresponsive NMIBC or BCG-Exposed, Chemotherapy-Unresponsive NMIBC

for
Nonmuscle-invasive Bladder Cancer
Location: New Brunswick NJ, Pittsburgh PA, Middleburg Heights OH,
Sponsor: ImmVira Pharma Co. Ltd

Sex: All

Age: 18+

Code: NCT06971614

Phase2, Recruiting

DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes

for
Gestational Diabetes Mellitus, Pregnancy, High Risk
Location: Philadelphia PA, New York NY, Providence RI,
Sponsor: Ohio State University

Sex: Female

Age: 18+

Code: NCT06445946

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

NS-089/NCNP-02-201 in Boys With Duchenne Muscular Dystrophy (DMD)

for
Duchenne Muscular Dystrophy, Exon 44, DMD
Location: Philadelphia PA, Pittsburgh PA, Richmond VA, London,
Sponsor: NS Pharma, Inc.

Sex: Male

Age: 4 - 14

Code: NCT05996003

Phase2, Recruiting

Systemic Hypothermia in Acute Cervical Spinal Cord Injury

for
Spinal Cord Injury, Acute
Location: Philadelphia PA, Baltimore MD, Columbia SC, Miami FL,
Sponsor: University of Miami

Sex: All

Age: 18 - 70

Code: NCT02991690

Recruiting

International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry

for
Gaucher Disease, Cerebroside Lipidosis Syndrome,
Location: Philadelphia PA, New Brunswick NJ, Morristown NJ,
Sponsor: Genzyme, a Sanofi Company

Sex: All

Age: 0+

Code: NCT00358943

Recruiting

VCRC Tissue Repository

for
Aortitis, Cutaneous Vasculitis,
Location: Philadelphia PA, Hamilton, Toronto
Sponsor: University of Pennsylvania

Sex: All

Age: 0+

Code: NCT02967068

Recruiting

Study to Evaluate R2R01 Plus Terlipressin Versus Terlipressin Alone in Patients With Hepatorenal Syndrome

for
Hepatorenal Syndrome, Acute Kidney Injury
Location: Philadelphia PA, Atlanta GA, Nashville TN, Rochester MN,
Sponsor: River 2 Renal Corp.

Sex: All

Age: 18+

Code: NCT05875948

Phase2, Recruiting

A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel

for
Multiple Myeloma
Location: Philadelphia PA, New Brunswick NJ, Hackensack NJ,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT05201781

Recruiting

A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)

for
Pemphigus Vulgaris
Location: Philadelphia PA, New York NY, New Haven CT, Boston MA,
Sponsor: Cabaletta Bio

Sex: All

Age: 18+

Code: NCT04422912

Phase1, Phase2, Recruiting

A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)

for
Graft-versus-host Disease (GVHD)
Location: Philadelphia PA, New York NY, Richmond VA, Boston MA,
Sponsor: Incyte Corporation

Sex: All

Age: 18+

Code: NCT06615050

Phase3, Recruiting

Performance of SGM-101 for the Delineation of Primary and Recurrent Tumor and Metastases in Patients Undergoing Surgery for Colorectal Cancer

for
Colorectal Neoplasms
Location: Philadelphia PA, Worcester MA, Weston FL, La Jolla CA,
Sponsor: Surgimab

Sex: All

Age: 18+

Code: NCT03659448

Phase3, Recruiting

Descemet Endothelial Thickness Comparison Trial II

for
Fuchs, Fuchs Dystrophy, Fuchs' Endothelial Dystrophy
Location: Philadelphia PA, Lebanon NH, Palm Beach Gardens FL,
Sponsor: Stanford University

Sex: All

Age: 18+

Code: NCT05275972

Phase3, Recruiting

Transcranial Magnetic Stimulation + Language Therapy to Treat Subacute Aphasia

for
Stroke, Aphasia, Aphasia Following Cerebral Infarction
Location: Philadelphia PA
Sponsor: University of Pennsylvania

Sex: All

Age: 18 - 70+

Code: NCT06968663

Phase2, Recruiting

GLP-1 Agonist Therapy in Cystic Fibrosis-Related Glucose Intolerance

for
Cystic Fibrosis, Pancreatic Insufficiency,
Location: Philadelphia PA, Aurora CO
Sponsor: University of Pennsylvania

Sex: All

Age: 18+

Code: NCT04731272

Phase2, Recruiting

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

for
Advanced Non-Small Cell Lung Cancer,
Location: East Brunswick NJ, Hackensack NJ, Teaneck NJ,
Sponsor: Mirati Therapeutics Inc.

Sex: All

Age: 18+

Code: NCT04613596

Phase2, Phase3, Recruiting

Generic Database of Very Low Birth Weight Infants

for
Infant, Newborn, Infant, Low Birth Weight,
Location: Philadelphia PA, Cleveland OH, Durham NC, Cincinnati OH,
Sponsor: NICHD Neonatal Research Network

Sex: All

Age: 0

Code: NCT00063063

Recruiting

A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma

for
Endometrial Adenocarcinoma
Location: New Brunswick NJ, Hackensack NJ, New York NY,
Sponsor: Acrivon Therapeutics

Sex: Female

Age: 18+

Code: NCT05548296

Phase2, Recruiting